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Abstract
Background: Psoriatic arthritis mutilans (PAM) is the most severe phenotype of psoriatic arthritis (PsA).
Purpose: To describe the radiological features in PAM and explore whether existing scoring systems for radiological
damage in psoriatic arthritis are applicable for PAM.
Material and Methods: Radiographs were scored according to the modified Sharp-van der Heijde (mSvdH) and the
Psoriatic Arthritis Ratingen Score (PARS) systems for PsA.
Results: At inclusion, 55 PAM patients (49% women, mean age 58 12 years) had conventional radiographs of both
hands and feet. A total of 869 PAM joints were detected and 193 joints with ankylosis. The mean total mSvdH score was
213.7 137.8 (41% of maximum) with a higher score for hands than for feet: 136.6 90.1 vs. 79.1 60.9. However, the
total score was relatively higher in the feet than in the hands when compared to the highest possible scoring (47% vs.
38% of max). The mean total PARS score was 126.3 79.6 (35% of max). Scoring for joint destruction was higher than
for proliferation (22% vs. 11% of max). Strong correlation was found between mSvdH and PARS (r2¼ 0.913). A signif-
icant correlation was found between scoring and duration of arthritis and the Health Assessment Questionnaire.
History of smoking, BMI, and gender did not influence the scoring values.
Conclusions: The two scoring systems studied may not be ideal to indicate progression of PAM in advanced disease
since they reach ceiling effects rather early. Therefore, reporting early signs suggestive of PAM, e.g. signs of pencil-in-cup
deformities or osteolysis, is crucial. This would reveal the presence of PAM and might lead to improved treatment in
order to minimize joint damage.
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Introduction
Psoriatic arthritis (PsA) belongs to a group of inflam-
matory joint disorders frequently associated with
enthesitis and dactylitis (1). PsA is classified as spondy-
loarthritis (SpA), which also includes axial SpA (previ-
ously named ankylosing spondylitis), reactive arthritis,
enteropathic arthritis associated with inflammatory
bowel diseases, and other undifferentiated arthritides.
The prevalence of PsA is reported to be in the range of
0.2%–0.3% in the Nordic countries (2,3), whereas up
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to 30% of patients with psoriasis may have significant
joint and muscle complaints (4,5).
The clinical presentation of PsA is multiform and
was described in detail 1973 by Moll and Wright in a
classical paper where they reported phenotypic charac-
teristics of patients with PsA (6). They presented five
main subtypes: oligoarthritis with less than four
peripheral joints involved; polyarthritis that may
mimic rheumatoid arthritis (RA); isolated involvement
of the distal interphalangeal joints in hands and feet;
axial involvement with inflammation in the small joints
and ligaments of the spine and the sacroiliac joints; and
finally the most severe phenotype, psoriatic arthritis
mutilans (PAM). The fact that PsA presents in multiple
forms may be the main reason for the delay in diagno-
sis, which in turn may delay effective modifying treat-
ment. Early diagnosis of PsA is essential for the future
wellbeing of the patient (7).
Internationally accepted diagnostic criteria for PsA
are essentially lacking. Most frequently, the criteria pro-
posed by Moll and Wright are used to confirm the diag-
nosis of PsA. The Group for Research and Assessment
of Psoriasis and Psoriatic Arthritis (GRAPPA) subse-
quently put forward the CASPAR criteria for classifi-
cation in clinical trials but these criteria are rarely used
in clinical practice (8). For PAM specifically, no definite
consensus has been established (9).
Characteristic clinical features of PAM include dig-
ital shortening, digital telescoping, and flail joints. The
radiographic features consist of osteolysis or extended
bone resorption, pencil-in-cup changes, joint subluxa-
tion, and, in some cases, ankylosis (10). The most
important and defining radiological feature is osteoly-
sis, which has been defined as bone resorption with-
>50% loss of joint surface on both sides of the joint
(11). Notably, involvement of one small joint in the
hands or feet is considered sufficient for the diagnosis
of PAM.
In the present study, we describe the radiological
features in 55 patients with PAM from the Nordic
PAM Study (12–14) and we also evaluate two different
scoring systems for radiological damage in PsA, to test
whether they are applicable for PAM.
Material and Methods
Patients
In the Nordic PAM Study, 67 patients were identified
in Sweden, Denmark, Norway, and Iceland. The diag-
nosis of PAM was confirmed according to the clinical
findings by experienced rheumatologists and dermatol-
ogists. All patients had at least one joint with severe
radiological destruction. Extended clinical data have
been reported on this patient group in two publications
(12,14). Complete plain radiographs of both hands and
feet were available for evaluation in 55/67 patients;
these 55 individuals constitute the patient population
of the present study (Table 1).
Collecting of radiographs
All radiographs were transferred digitally and collected
at the Helsinki Medical Imaging Center where an expe-
rienced radiologist (LL), unaware of the demography
of the individual patients, scored all radiographs.
Among available scoring instruments, the Sharp-van
der Heijde modified scoring method for PsA
(mSvdH) (15,16) and the Psoriatic Arthritis Ratingen
Score (PARS) (16) were applied. Mainly posterior–
anterior projections were used, but in very deformed
joints other projections could also be included when
available.
Radiographic assessment
The mSvdH method is based on assessing erosions and
joint space narrowing in RA (16), but when applied for
PsA also includes the distal interphalangeal joints
(DIP) of the hands. Thus, the joint assessment for
PsA includes 40 joints in the hands and 12 joints in
the feet. Erosions are graded on a scale of 0–5 in the
hands and 0–10 in the feet. Joint space narrowing is
graded on a scale of 0–4. Thus, the maximum score for
erosions is 200 for the hands and 120 for the feet, and
for joint space narrowing 160 for the hands and 48 for
the feet. The maximum scores are 320 for erosions, 208
for joint space narrowing, and therefore 528 points for
the total score. Thus, maximum scores calculated for
the hands and feet separately are 360 versus 168.
The PARS scoring method was developed specifi-
cally for the radiographic assessment of PsA (16,17).
Table 1. Demographic data of 55 patients with PAM in whom
radiographs of hands and feet were available for evaluation.
PAM patients included
in present study (n¼ 55)
Gender (female/male) (n) 27/28
Mean age (years) 58 12
Age at onset of Pso (years) 26 15
Age at onset of PsA (years) 32 15
Disease duration Pso (years) 32 15
Disease duration PsA (years) 27 13
HAQ 0.96 0.78
CRP (mg/L) 7.1 9.0
BMI (kg/m2) 25.8 5.8
Values are given as mean SD unless otherwise specified.
BMI, body mass index; CRP, C-reactive protein; HAQ, Health Assessment
Questionnaire; PAM, psoriatic arthritis mutilans; PsA, psoriatic arthritis;
Pso, psoriasis.
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In the hand, DIPs, thumb interphalangeal (IP) joint,
proximal interphalangeal (PIP) joints, metacarpopha-
langeal (MCP) joints, wrists, and in the feet IP joints of
the great toe, and metatarsophalangeal (MTP) joints
II–V are assessed for destruction (destruction score
[DS]) on a 6-point scale and proliferation (proliferation
score [PS]) on a 5-point scale. The maximum DS score
for the hands are 150 and for the feet 50, and the max-
imum PS is 120 for the hands and 40 for the feet. The
combined maximum scores are thus 200 for DS and
160 for PS, with a total score of 360 for each patient.
Correlation with clinical parameters
The total scores of mSvdH and PARS were also corre-
lated to various clinical characteristics such as gender,
duration of arthritis, the Health Assessment
Questionnaire (HAQ), body mass index (BMI), and
history of smoking.
Data analysis
The data were processed and analyzed using R version
3.6.1 and RStudio version 1.2.1335 on a machine run-
ning Linux Mint 19.1 Tessa. The R package version
1.2.1 was used to read the data into RStudio, process
it, and compute the sample mean of the variables of
interest along with their sample SD. Furthermore, all
plots based on the processed data were generated with
R package ggplot2 version 3.2.1.
To determine the sample correlation between two
variables and test the significance of the relationship,
base R functions cor and cor.test were applied. The
significance test of choice was the two-tailed
Pearson’s correlation test. The null hypothesis of such
as test is that correlation between two variables is 0 and
its test statistic is t-distributed.
Lastly, simple linear regression was performed on
variables total mSvdH and total PARS, with total
PARS as the dependent variable. As the regression
was simple, the coefficient of determination r^2,
which measures the proportion of variance in total
PARS explained by total mSvdH, was reduced to the
square of the correlation between total PARS and total
mSvdH.
Ethical issues
Written informed consent was obtained from all par-
ticipants in the study. Bioethics Committees and Data
Protection Authorities in all four countries approved
the study protocol.
Results
Patient population
Fifty-five patients with PAM (27 women, 28 men; mean
age¼ 58 12 years) in the Nordic PAM Study had
conventional radiographs of both hands and feet at
the time point of inclusion in the study. Age, gender
difference, and disease duration of psoriasis (Pso) and
PsA (Table 1) were almost identical in the present study
group as for the whole Nordic PAM Study group
(12,14). Most patients (n¼ 51) suffered from polyartic-
ular disease, three had oligoarthritis, and one patient
suffered from mono-articular disease.
Fig. 1 illustrates an example of the most common
feature of PAM: osteolysis, pencil-in-cup, subluxation,
proliferation and ankylosis, which may all be present in
the same patient. In addition, Fig. 2 demonstrates the
clinical and radiographic findings for another patient.
Results from mSvdH score
The mean total score evaluated by mSvdH was 213.7
 137.4; that is, 41.4% of the highest possible score
of 528 (Fig. 3). The total scores in the hands were
higher than in the feet (136.6 90.1 vs. 79.1 60.9)
but when the scores were expressed as a percent of
the possible maximum scores, the reverse was seen
(37.8% of max scoring of 360 vs. 47.1% of 168).
The number of joints that received maximal scores
due to gross osteolysis and/or pencil-in-cup deformities
Fig. 1. Radiography of a 66-year-old female patient with psori-
atic arthritis mutilans with a history psoriatic arthritis of 27 years
with all the five classical sign of arthritis mutilans.
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Fig. 2. A 66-year-old man with a 32-year history of PAM. His hands show classical sign of severe PAM deformity with shortening or
digital telescoping of his fingers with flail joints (left), and the radiograph (right) shows profound osteolysis in several joints and pencil-
in-cup deformities (MCP IV) of his hand with relative sparing changes of his wrists and no sign of ankylosis. PAM, psoriatic arthritis
mutilans.
Fig. 3. Distribution of the total scores in 55 patients with PAM in the Nordic PAM study, evaluated by mSvdH (maximum scoring
360) and PARS (maximum scoring of 528) scoring systems for radiologic changes in hands and feet. The scores are shown in
correlation to the highest possible score. PAM, psoriatic arthritis mutilans.
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was 306, of which 194 joints were found with classical
pencil-in-cup deformity: 98 in the hands and 96 in the
feet in 38 patients.
Results from PARS
When evaluated according to PARS, themean total score
was 126.3 79.6 (max scoring¼ 360), or 35.1% of the
highest possible scoring (Fig 3). In general, the PARS
for destruction (DS) and proliferation (PS) are presented
separately, in addition to the total score. There were
higher scores for DS than for PS or 44.8 39.2 (22.4%
of maximum 200) vs. 18.3 19.1 (11.4% of 160)
The scores were assessed for both destruction and
proliferation for hands and feet separately. The DS in
the hands was 63.9 44.5, reflecting 42.5% of the max-
imal score of 150. The PS was 28.3 21.1 (23.6% of
120) and the total score was 92.2 63.2 (34.1% of 270).
In the feet, DS was 25.7 19.1 (51.4% of 50), PS 8.4
 9.1 (21.1% of 40), and the total score was 34.1
 26.0 (34.9% of 90) (Fig. 4).
Fig. 5 demonstrates the correlation (r¼ 0.956;
P< 0.0001) between the total scores of mSvdH and
PARS in 55 patients with PAM and the total score of
PARS was explained 91% by mSvdH (R¼ 913).
Correlation with clinical parameters
A significant correlation was found between the radio-
logical severity of the disease by both scoring methods
(mSvdH and PARS) and the duration of arthritis and
the patient’s age at onset of arthritis. The duration of
psoriasis showed a higher correlation with PARS than
with the mSvdH score. A significant correlation was
also found between both scoring methods and the
HAQ score (Table 2).
The mean mSvdH scores were found also to be sim-
ilar in non-smokers (n¼ 32; mSvdH¼ 181.4 110), in
patients who had stopped smoking (n¼ 14; 204.1
 147), and in current smokers (n¼ 9; 169.0 85).
A weak correlation was observed with C-reactive pro-
tein (CRP) with both scoring systems but was only sig-
nificant for PARS (Table 2). No correlation was found
with the patient’s age at the time of the study, or with
the age at onset of psoriasis, BMI, or gender.
In addition to the joints included in the scoring sys-
tems, all peripheral joints, including the DIP and PIP
joints of the feet, were analyzed for the presence of resorp-
tion of >50% of the joint surface on both sides of the
joint space (“PAM joints”) and ankylosis. A total of 869
PAM joints with >50% resorption were detected (28% of
all examined joints; Table 3) and 193 joints with ankylosis;
112 (7.3%) in the hands and 78 (5.1%) in the feet. In
addition, 74 operated joints were found in the small
joints of hands and feet in these 55 patients with PAM.
Discussion
In the present study, we have reviewed individual
radiographs of patients participating in the Nordic
Fig. 4. Distribution of total Psoriatic Arthritis Ratingen Score in 55 patients with PAM in the Nordic PAM study; scores for
destruction (max scores 200) and proliferation (max scores 160) for hands and feet are given separately. The scores are shown
in correlation to the highest possible score. PAM, psoriatic arthritis mutilans.
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PAM Study (12,14). However, we only included
patients where radiographs of both hands and feet
were available at time of inclusion for evaluation
according to standard scoring methods. Notably, the
demographic profile of the 55 patients analyzed herein
was similar to the whole population in the Nordic
PAM study.
Even though scoring of radiographs is mostly used
for research purposes, it may be useful for everyday
radiologists to be familiar with PsA scoring instru-
ments and their limitations. These instruments may
serve as valuable tools in the diagnostic process of
PAM since radiographic change may precede clinical
findings (18). All small joints in the hands and feet
should be examined carefully and any suspected finding
of destruction, osteolysis, or proliferation should be
reported to the clinician as potential indication for
development of PAM. In advanced disease where struc-
tural abnormalities are expected, plain radiographs are
useful. However, in early arthritis, magnetic resonance
imaging (MRI) is the method of choice, as it detects
minimal disease activity, such as synovitis in the small
joints, osteitis or bone edema, and enthesitis, as well as
dactylitis (19). However, MRI findings are less sensitive
to distinguish between different rheumatic disorders.
The most challenging task is to differentiate between
early PsA and osteoarthritis (20). Interestingly, in
arthritis mutilans, high bone edema scores have been
found to correlate with high radiographic scores (21),
but not with clinical variables reflecting disease activity.
This suggests that bone damage may not necessarily be
coupled to local joint inflammation in PsA but rather
Table 2. Pearson’s correlation of radiographic scoring systems by the mSvdH and PARS in 55 patients with PAM with
clinical findings.
PARS mSvdH
Onset of psoriasis 20.27* (0.5–0.01) 0.26 (0.49–0.0)
Onset of arthritis 0.37 (0.58–0.11) 20.4* (0.6–0.15)
Duration of psoriasis 0.42* (0.17–0.6) 0.36* (0.10.57)
Duration of arthritis 0.51* (0.28–0.7) 0.48* (0.250.66)
HAQ 0.52* (0.28–0.7) 0.51* (0.26–069)
BMI 0.13 (0.39–0.14) 0.21 (0.45–0.05)
CRP 0.34* (0.07–0.57) 0.27 (0.01–0.51)
Values in parentheses are 95% confidence intervals.
*Significant difference (p< 0.05).
BMI, body mass index; CRP, C-reactive protein; HAQ, Health Assessment Questionnaire; mSvdH, modified Sharp-van der Heijde score;
PARS, Psoriatic Arthritis Ratingen Score.
Fig. 5. The correlation between the Sharp-van der Heijde modified scoring method for psoriatic arthritis and Psoriatic Arthritis
Ratingen Score in 55 patients with PAM in the Nordic PAM study. PAM, psoriatic arthritis mutilans.
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reflective of systemic inflammation. Possibly support-
ing this notion is the correlation, albeit only weakly
significant, between levels of CRP and radiographic
scores in the present study. We have not been able to
find an MRI study specifically focusing on PAM,
which would be an interesting topic for future research.
The radiographic scoring methods used herein are
well documented and validated. Tillett et al. (22) found
that the mSvdH method is reliable and sensitive to
change but is time-consuming. The PARS seems
more sensitive for the detection of minimal change.
The main advantage of PARS is that it scores the pres-
ence of proliferation, which is a hallmark of PsA.
Therefore, we chose PARS as the second instrument.
However, in our patients with PAM, destruction was
more pronounced than proliferation. This is in contrast
to the findings in the Swedish study of early PsA (23),
where proliferation scores were higher than destruction
scores. When osteolysis progresses, the degree of pro-
liferation seems to diminish. In our patients with PAM,
PARS correlated closer with the duration of PsA.
The two methods that we used cannot be directly
compared in our study set-up as the maximum scores
are quite different for the two methods—528 for
mSvdH and 360 for PARS—but in correlation with
other features a comparison is useful. The same prob-
lem arises when comparing destruction and prolifera-
tion scores (max 200 points vs. 160 points). We
therefore evaluated the scoring in relation to the high-
est possible score. Another problem is that in advanced
disease there is often a ceiling effect, which may require
yet a different scoring method, e.g. the osteolysis score
described by Jadon et al. (11). In this method, osteol-
ysis is scored as blocks of bone. This could help in
determining progression in severely deformed joints,
e.g. PAM and in clinical trials to follow-up on radio-
logic progression, while the method is not easily
adapted for analysis of one single radiograph.
Furthermore, mSvdH does not include all involved
joints and four of our patients had only sign of PAM
in their small joints of the feet, which are not included
in these two scoring systems.
Our patient population was rather heterogeneous.
Most patients had polyarticular disease. Additionally,
the disease duration varied considerably, or up to 30
years for psoriasis and 26 years for the arthritis condi-
tion. Mutilans involvement was observed at all joint
levels in the small joints in the present study. Even
though DIP joints are frequently described as typically
affected in PsA, there was only a slight predominance
of destruction in the DIP joints of the hands, whereas
the MTP joints were most frequently affected in the
feet. Ankylosis was much less frequently reported in
our patients, which is probably why it has not been
regarded as a defining feature of PAM (24). We also
analyzed the smoking habits of the patients, but smok-
ing did not seem to be an important factor, which is an
unexpected finding as smoking is considered a risk
factor for arthritis and associates with worse treatment
outcomes in PsA as well as in RA.
In conclusion, the two scoring systems studied,
mSvdH and PARS, have limitations in advanced dis-
ease, as they reach the so-called ceiling effects relatively
early. Therefore, they are probably not suitable to indi-
cate progression of PAM in the individual patient. The
scoring system described by Jodon (11), based on signs
of osteolysis, may be more appropriate in this setting.
Therefore, it is of high importance that radiologists
report early signs suggestive of PAM, e.g. signs of
pencil-in-cup deformities or osteolysis in any joint.
Early reporting is crucial and should be mandatory.
This would alert the clinician, accelerate the diagnosis,
and hopefully lead to improved effective treatment in
order to minimize joint damage resulting in PAM.
Acknowledgments
The authors thank all patients who participated in the study;
Thomas Ternowitz, Department of Dermatology, Stavanger
University Hospital, Norway, for collecting Norwegian data;
Kerstin Berg, Karolinska Institutet, Stockholm, Sweden, for
data handling; and finally, NORDPSO for their economic
support of the Nordic PAM Study.
Declaration of conflicting interests
The author(s) declared no potential conflicts of interest with
respect to the research, authorship, and/or publication of this
article.
Table 3. Distribution of severely destructed joints with> 50%
destruction of the joint surface on both sides of the joint, i.e.
classical “mutilans joints”, in 55 patients with PAM in the Nordic
PAM study.
Right Left Total Joints (n)
Involved
joints (%)
Feet
DIP/IP 73 74 147 550 26.7
PIP 64 64 128 440 29.1
MTP 98 110 208 550 37.8
Hands
DIP/IP 68 69 137 550 24.9
PIP 55 65 120 440 27.3
MCP 65 67 128 550 23.3
The number of assessed joints together with the percentage of affected
joints is also presented.
DIP, distal interphalangeal joints; IP, interphalangeal; MCP metacarpo-
phalangeal joints; MTP, metatarsophalangeal; PAM, psoriatic arthritis
mutilans; PIP, proximal interphalangeal.
Laasonen et al. 7
Funding
The author(s) received no financial support for the research,
authorship, and/or publication of this article.
ORCID iD
Bjorn Gudbjornsson https://orcid.org/0000-0003-4631-
6505
References
1. Ritchlin CT, Colbert RA, Gladman DD. Psoriatic
Arthritis. N Engl J Med 2017;376:957–970.
2. Scotti L, Franchi M, Marchesoni A, et al. Prevalence and
incidence of psoriatic arthritis: a systematic review and
meta-analysis. Seminar Arthritis Rheum 2018;48:28–34.
3. Love TJ, Gudbjornsson B, Gudjonsson JE, et al.
Psoriatic arthritis in Reykjavik, Iceland: Prevalence, dem-
ographics, and disease course. J Rheumatol
2007;34:2082–2088.
4. Zachariae H, Zachariae R, Blomqvist K, et al. Quality of
life and prevalence of arthritis reported by 5,795 members
of the Nordic Psoriasis Associations. Data from the
Nordic Quality of Life Study. Acta Derm Vererol
2002;82:108–113.
5. Langley RG, Krueger GG, Griffiths CE. Psoriasis:
Epidemiology, clinical features, and quality of life. Ann
Rheum Dis 2005;64(Suppl. 2):18–23.
6. Moll J. M., Wright V. Psoriatic arthritis. Semin Arthritis
Rheum 1973;3:55–78.
7. McHugh NJ. Verna Wright Lecture: Psoriatic Arthritis:
the need for early intervention. J Rheumatol Suppl
2015;93:10–13.
8. Taylor W, Gladman D, Helliwell P, et al. Classification
criteria for psoriatic arthritis: Development of new crite-
ria from a large international study. Arthritis Rheum
2006;54:2665–2673.
9. Chandran V, Gladman DD, Helliwell, et al. Arthritis
mutilans: a report from the GRAPPA 2012 annual meet-
ing. J Rheumatol 2013;40:1419–1422.
10. Haddad A, Johnson SR, Somaily M, et al. Psoriatic
arthritis mutilans: clinical and radiographic criteria: A
systematic review. J Rheumatol 2015;42:1432–1438.
11. Jadon DR, Shaddick, Tillett W, et al. Psoriatic arthritis
mutilans: characteristics and natural radiographic histo-
ry. J Rheumatol 2015;42:1169–1176.
12. Gudbjornsson B, Ejstrup L, Gran JT, et al. Psoriatic
arthritis mutilans (PAM) in the Nordic countries:
demographics and disease status. The Nordic PAM
study. Scand J Rheumatol 2013;42:373–378.
13. Laasonen L, Gudbjornsson B, Ejstrup L, et al.
Radiographic development during three decades in a
patient with psoriatic arthritis mutilans. Acta Radiol
Open. 2015;4:2058460115588098.
14. Lindqvist U, Gudbjornsson B, Iversen L, et al. Disease
activity in and quality of life of patients with psoriatic
arthritis mutilans: The Nordic PAM Study. Scand J
Rheumatol 2017;46:454–460.
15. van der Heijde DM. How to read radiographs according
to the Sharp/van der Heijde method. J Rheumatol
1999;26:743–745.
16. van der Heijde D, Sharp J, Wassenberg S, et al. Psoriatic
arthritis imaging: a review of scoring methods. Ann
Rheum Dis 2005;64(Suppl. II):61–64.
17. Wassenberg S, Fischer-Kahle V, Her-Born G, et al. A
method to score radiographic change in psoriatic arthri-
tis. J Rheumatol 2001;60:156–166.
18. Haroon M, Gallagher P, FitzGerald O. Diagnostic delay
of more than 6 months contributes to poor radiographic
and functional outcome in psoriatic arthritis. Ann
Rheum Dis 2015;74:1045–1050.
19. Poggenborg RP, S€orensen IJ, Pedersen SJ, et al.
Magnetic resonance imaging for diagnosing, monitoring
and prognostication in psoriatic arthritis. Clin Exp
Rheumatol 2015;33(Suppl. 93):66–69.
20. Braum LS, McGonagle, Bruns A, et al. Characterization
of hand small joint arthropathy using high-resolution
MRI – Limited discrimination between osteoarthritis
and psoriatic arthritis. Eur Radiol 2013;23:1686–1693.
21. Tan YM, €Ostergaard M, Doyle A, et al. MRI bone
oedema scores are higher in the arthritis mutilans form
of psoriatic arthritis and correlate with high radiographic
scores for joint damage. Arthritis Res Ther 2009;11:R2.
22. Tillett W, Jadon D, Shaddick G, et al. Feasibility, reli-
ability, and sensitivity to change of four radiographic
scoring methods in patients with psoriatic arthritis.
Arthritis Care Res 2014;66:311–317.
23. Geijer M, Lindqvist U, Husmark T, et al. The Swedish
early psoriatic arthritis registry 5-year followup:
Substantial radiographic progression mainly in men
with high disease activity and development of dactylitis.
J Rheumatol 2015;42:2110–2117.
24. Acosta Felquer ML, FitzGerald O. Peripheral joint
involvement in psoriatic arthritis patients. Clin Exp
Rheumatol 2015:33(Suppl. 93):26–30.
8 Acta Radiologica Open
